The US Food and Drug Administration has just warned consumers to immediately stop using the dietary supplement Hydroxycut, because of an association between the Hydroxycut products and a number of serious liver and other injuries. Made by Iovate Health Sciences Inc. (Oakville, Ontario) and distributed by Iovate Health Sciences USA Inc. (Blasdell, N.Y.), the manufacturer has agreed to recall their products from the market. The actual FDA warning can be found at http://www.fda.gov/bbs/topics/NEWS/2009/NEW02006.html. The FDA received several reports of serious health problems including: Jaundice Elevated liver enzymes Liver failure Seizures Cardiovascular disorders Rhabdomyolysis There was a report of liver damage so severe it caused one person to die of liver disease and an undisclosed number of people who required liver transplants. These lower-cost Hydroxycut products were marketed for weight-loss, as fat burners, as energy-enhancers, as low carb diet aids, and for water loss under the Iovate and MuscleTech brand names. Although the FDA has not received reports on all of the associated products, Iovate agreed to recall the following products:
Hydroxycut Regular Rapid Release Caplets
Hydroxycut Caffeine-Free Rapid Release Caplets
Hydroxycut Hardcore Liquid Caplets
Hydroxycut Max Liquid Caplets
Hydroxycut Regular Drink Packets
Hydroxycut Caffeine-Free Drink Packets
Hydroxycut Hardcore Drink Packets (Ignition Stix)
Hydroxycut Max Drink Packets
Hydroxycut Liquid Shots
Hydroxycut Hardcore RTDs (Ready-to-Drink)
Hydroxycut Max Aqua Shed
Hydroxycut 24
Hydroxycut Carb Control
Hydroxycut Natural
It has been reported that a 19 year old young man died after using Hydroxycut in 2007, but the FDA was not made aware of this until 2009. The company denies there is any association between the cause and affect of these supplements and the injuries. More investigation will be required. If you have suffered an injury you believe is related to any of these products, contact one of our dangerous drug and pharmaceutical litigation lawyers to see if further inquiry is recommended.